indomethacin has been researched along with Bleeding Between Periods in 1 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
Excerpt | Relevance | Reference |
---|---|---|
"Fewer bleeding and spotting days were observed in the 90-day reference period for the 3 indomethacin/levonorgestrel-releasing intrauterine system dose groups than for the levonorgestrel-releasing intrauterine system without indomethacin group." | 3.30 | The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial. ( Costescu, D; Fels, LM; Hofmann, BM; Klein, S; Lindenthal, B; Lukkari-Lax, E; Peipert, JF; Reinecke, I; Speer, R; Vieira, CS; Wiesinger, K, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Fels, LM | 3 |
Costescu, D | 3 |
Vieira, CS | 3 |
Peipert, JF | 3 |
Lukkari-Lax, E | 3 |
Hofmann, BM | 3 |
Reinecke, I | 3 |
Klein, S | 3 |
Wiesinger, K | 3 |
Lindenthal, B | 3 |
Speer, R | 3 |
1 trial available for indomethacin and Bleeding Between Periods
Article | Year |
---|---|
The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial.
Topics: Bayes Theorem; Contraceptive Agents, Female; Female; Humans; Indomethacin; Intrauterine Devices, Med | 2023 |
The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial.
Topics: Bayes Theorem; Contraceptive Agents, Female; Female; Humans; Indomethacin; Intrauterine Devices, Med | 2023 |
The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial.
Topics: Bayes Theorem; Contraceptive Agents, Female; Female; Humans; Indomethacin; Intrauterine Devices, Med | 2023 |
The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial.
Topics: Bayes Theorem; Contraceptive Agents, Female; Female; Humans; Indomethacin; Intrauterine Devices, Med | 2023 |
The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial.
Topics: Bayes Theorem; Contraceptive Agents, Female; Female; Humans; Indomethacin; Intrauterine Devices, Med | 2023 |
The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial.
Topics: Bayes Theorem; Contraceptive Agents, Female; Female; Humans; Indomethacin; Intrauterine Devices, Med | 2023 |
The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial.
Topics: Bayes Theorem; Contraceptive Agents, Female; Female; Humans; Indomethacin; Intrauterine Devices, Med | 2023 |
The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial.
Topics: Bayes Theorem; Contraceptive Agents, Female; Female; Humans; Indomethacin; Intrauterine Devices, Med | 2023 |
The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial.
Topics: Bayes Theorem; Contraceptive Agents, Female; Female; Humans; Indomethacin; Intrauterine Devices, Med | 2023 |